(Q33827422)

29 July 2017

Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide (English)

1 reference

29 July 2017

Andrea Remuzzi

5

0 references

Giuseppe Remuzzi

object named as

Giuseppe Remuzzi

series ordinal

6

0 references

Piero Ruggenenti

series ordinal

7

object named as

Piero Ruggenenti

1 reference

29 July 2017

1

Anna Caroli

1 reference

29 July 2017

3

Mariateresa Cafaro

1 reference

29 July 2017

4

Giorgio Fasolini

1 reference

29 July 2017

Luca Antiga

2

1 reference

29 July 2017

25 February 2010

1 reference

Clinical Journal of the American Society of Nephrology

29 July 2017

1 reference

29 July 2017

5

1 reference

29 July 2017

5

1 reference

29 July 2017

783-789

1 reference

PubMed ID

20185596

describes a project that uses

29 July 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2863977/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863977

The 1993-94 Généthon human genetic linkage map

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863977

Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863977

Somatostatin analogues reduce liver volume in polycystic liver disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863977

Liver volume variation in patients with virus-induced cirrhosis: findings on MDCT.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863977

Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863977

Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863977

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863977

cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863977

Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease

29 October 2018

1 reference

12 December 2020

Cyclic AMP, at the hub of the cystic cycle

1 reference

12 December 2020

Autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort

1 reference

12 December 2020

Octreotide LAR for the treatment of acromegaly

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.05380709

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

PubMed ID

20185596